Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ARDS - Aridis Pharmaceuticals Inc

N/A
0   0%

Share volume: 0
Last Updated: Fri 30 Aug 2024 11:00:08 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
36%
Profitability 43%
Dept financing 23%
Liquidity 37%
Performance 33%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
-98.33%
6 Months
-98.70%
1 Year
-98.75%
2 Year
-99.63%
Key data
Stock price
N/A
P/E Ratio 
0.00
DAY RANGE
N/A - $0.31
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.12
52 WEEK CHANGE
-$0.99
MARKET CAP 
53.321 K
YIELD 
N/A
SHARES OUTSTANDING 
53.321 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$6,250
AVERAGE 30 VOLUME 
$4,193
Company detail
CEO:
Region: US
Website: aridispharma.com
Employees: 17
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

aridis is a privately held infectious diseases focused company in san jose, ca, usa. aridis’ advanced formulation and delivery technologies are combined with proprietary products portfolio to create potent drug candidates that are packaged into convenient to administer, "ready-to-use" formats.

Recent news